Literature DB >> 9539163

Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor.

E Maquoi1, A Noël, F Frankenne, H Angliker, G Murphy, J M Foidart.   

Abstract

The close correlation observed between matrix metalloproteinase 2 (MMP-2) activation and metastatic progression in various tumors suggests that MMP-2 is a 'master switch' triggering tumor spread. Recently, membrane type 1 MMP (MT1-MMP) was identified as a potential physiological activator of MMP-2. Like all other MMPs, MT1-MMP possesses a pro-domain which must be removed for the enzyme to acquire its catalytic potential. The presence of a typical recognition motif (RXKR) for the furin-like convertases at the end of its pro-domain suggests a potential role for these proteinases in MT1-MMP processing. In order to evaluate the implication of furin in pro-MT1-MMP processing, we treated HT1080 cells with a synthetic furin inhibitor and monitored their ability to activate pro-MMP-2 as well as their invasive potential. Our results demonstrated that the furin inhibitor decreased pro-MT1-MMP processing as well as pro-MMP-2 activation and cell invasiveness. Therefore, our data bring further evidence that furin is a key factor in the maturation of MMPs associated with the invasive and metastatic potential of tumor cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539163     DOI: 10.1016/s0014-5793(98)00187-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Mixed Nanosized Polymeric Micelles as Promoter of Doxorubicin and miRNA-34a Co-Delivery Triggered by Dual Stimuli in Tumor Tissue.

Authors:  Giuseppina Salzano; Daniel F Costa; Can Sarisozen; Ed Luther; George Mattheolabakis; Pooja P Dhargalkar; Vladimir P Torchilin
Journal:  Small       Date:  2016-07-19       Impact factor: 13.281

2.  Vascular smooth muscle cell motility: From migration to invasion.

Authors:  Sherif F Louis; Peter Zahradka
Journal:  Exp Clin Cardiol       Date:  2010

3.  Furin inhibitor D6R suppresses epithelial-mesenchymal transition in SW1990 and PaTu8988 cells via the Hippo-YAP signaling pathway.

Authors:  Meng Zhou; Youli Zhang; Hong Wei; Junbo He; Dawei Wang; Baoding Chen; Jian Zeng; Aihua Gong; Min Xu
Journal:  Oncol Lett       Date:  2017-12-20       Impact factor: 2.967

Review 4.  Inhibitors of proprotein convertases.

Authors:  Ajoy Basak
Journal:  J Mol Med (Berl)       Date:  2005-10-08       Impact factor: 4.599

5.  Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme.

Authors:  C M Dubois; F Blanchette; M H Laprise; R Leduc; F Grondin; N G Seidah
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

6.  Regulation of membrane-type 1 matrix metalloproteinase activity by vacuolar H+-ATPases.

Authors:  Erik Maquoi; Karine Peyrollier; Agnès Noël; Jean-Michel Foidart; Francis Frankenne
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

7.  The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP.

Authors:  Jin-Ah Cho; Pamela Osenkowski; Huiren Zhao; Seaho Kim; Marta Toth; Kristina Cole; Amro Aboukameel; Allen Saliganan; Lucia Schuger; R Daniel Bonfil; Rafael Fridman
Journal:  J Biol Chem       Date:  2008-04-15       Impact factor: 5.157

8.  S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells.

Authors:  Berit Mathisen; Rune I Lindstad; Janne Hansen; Sara Ann El-Gewely; Gunhild M Maelandsmo; Eivind Hovig; Oystein Fodstad; Thrina Loennechen; Jan-Olof Winberg
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion.

Authors:  Vera Brekhman; Gera Neufeld
Journal:  BMC Cancer       Date:  2009-11-30       Impact factor: 4.430

10.  Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts.

Authors:  Kirsten Riches; Michael E Morley; Neil A Turner; David J O'Regan; Stephen G Ball; Chris Peers; Karen E Porter
Journal:  J Mol Cell Cardiol       Date:  2009-06-11       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.